BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications

 BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications

BMS Collaborates with Voluntis to Co-Develop Digital Therapies for Cancer

Shots:

  • The collaboration will deploy Voluntis’ Theraxium Oncology, a platform for digital therapies in oncology and will evaluate potential solutions to support the management of patients symptoms & remote monitoring by HCPs
  • The focus of the collaboration is to develop digital therapies, providing patients access to a mobile app to support the treatment and track symptoms. The companies will evaluate how digital solutions enable patients to communicate with their HCPs, track symptoms and receive a personalized supportive care plan
  • The app will be developed to entrench evidence-based algorithms intended to provide patients with real-time recommendations for self-management of symptoms regarding therapy

Click here ­to­ read full press release/ article | Ref: BMS | Image: Voluntis

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post